Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination

NeuroImage

Volumn 125, Issue , 2016, Pages 363-377

  Guglielmetti, C ^a   Veraart, J ^a,b   Roelant, E ^a   Mai, Z ^a   Daans, J ^a   Van Audekerke, J ^a   Naeyaert, M ^a   Vanhoutte, G ^a   Delgado y Palacios, R ^a   Praet, J ^a   Fieremans, E ^b   Ponsaerts, P ^a   Sijbers, J ^a   Van der Linden, A ^a   Verhoye, M ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cuprizone; Demyelination; Diffusion; Grey matter; Kurtosis; White matter

Indexed keywords

CUPRIZONE; CHELATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN RADIOGRAPHY; CONTROLLED STUDY; CONVALESCENCE; CORPUS CALLOSUM; DEMYELINATION; DIFFUSION KURTOSIS IMAGING; DISEASE SEVERITY; FEMALE; GLIOSIS; GRAY MATTER; MOTOR CORTEX; MOUSE; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; REMYELINIZATION; SOMATOSENSORY CORTEX; WHITE MATTER LESION; ANIMAL; BRAIN CORTEX; C57BL MOUSE; CHEMICALLY INDUCED; DEMYELINATING DISEASE; DIFFUSION TENSOR IMAGING; DISEASE MODEL; DRUG EFFECTS; PATHOLOGY; PROCEDURES; WHITE MATTER;

ANIMALS; CEREBRAL CORTEX; CHELATING AGENTS; CUPRIZONE; DEMYELINATING DISEASES; DIFFUSION TENSOR IMAGING; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED C57BL; WHITE MATTER;

EID: 84945587900     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2015.10.052     Document Type: Article

References (105)

1. Acs P., Kipp M., Norkute A., Johann S., Clarner T., Braun A., Berente Z., Komoly S., Beyer C. 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice. Glia 2009, 57:807-814.
2. Alexander A.L., Lee J.E., Lazar M., Field A.S. Diffusion tensor imaging of the brain. Neurotherapeutics 2007, 4:316-329.
3. Baloch S., Verma R., Huang H., Khurd P., Clark S., Yarowsky P., Abel T., Mori S., Davatzikos C. Quantification of brain maturation and growth patterns in C57BL/6J mice via computational neuroanatomy of diffusion tensor images. Cereb. Cortex 2009, 19:675-687.
4. Bando Y., Takakusaki K., Ito S., Terayama R., Kashiwayanagi M., Yoshida S. Differential changes in axonal conduction following CNS demyelination in two mouse models. Eur. J. Neurosci. 2008, 28:1731-1742.
5. Basser P.J. Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed. 1995, 8:333-344.
6. Basser P.J., Jones D.K. Diffusion-tensor MRI: theory, experimental design and data analysis - a technical review. NMR Biomed. 2002, 15:456-467.
7. Basser P.J., Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J. Magn. Reson. B 1996, 111:209-219.
8. Beaulieu C. The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed. 2002, 15:435-455.
9. Benardais K., Kotsiari A., Skuljec J., Koutsoudaki P.N., Gudi V., Singh V., Vulinovic F., Skripuletz T., Stangel M. Cuprizone [bis(cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes. Neurotox. Res. 2013, 24:244-250.
10. Benitez A., Fieremans E., Jensen J.H., Falangola M.F., Tabesh A., Ferris S.H., Helpern J.A. White matter tract integrity metrics reflect the vulnerability of late-myelinating tracts in Alzheimer's disease. Neuroimage Clin. 2014, 4:64-71.
11. Bester M., Jensen J., Babb J., Tabesh A., Miles L., Herbert J., Grossman R., Inglese M. Non-Gaussian diffusion MRI of gray matter is associated with cognitive impairment in multiple sclerosis. Mult. Scler. 2015, 21:935-944.
12. Blockx I., De Groof G., Verhoye M., Van Audekerke J., Raber K., Poot D., Sijbers J., Osmand A.P., Von Horsten S., Van der Linden A. Microstructural changes observed with DKI in a transgenic Huntington rat model: evidence for abnormal neurodevelopment. NeuroImage 2012, 59:957-967.
13. Blockx I., Verhoye M., Van Audekerke J., Bergwerf I., Kane J.X., Delgado Y.P.R., Veraart J., Jeurissen B., Raber K., von Horsten S., Ponsaerts P., Sijbers J., Leergaard T.B., Van der Linden A. Identification and characterization of Huntington related pathology: an in vivo DKI imaging study. NeuroImage 2012, 63:653-662.
14. Boretius S., Escher A., Dallenga T., Wrzos C., Tammer R., Bruck W., Nessler S., Frahm J., Stadelmann C. Assessment of lesion pathology in a new animal model of MS by multiparametric MRI and DTI. NeuroImage 2012, 59:2678-2688.
15. Buschmann J.P., Berger K., Awad H., Clarner T., Beyer C., Kipp M. Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelination. J. Mol. Neurosci. 2012, 48:66-76.
16. Calabrese M., Rinaldi F., Seppi D., Favaretto A., Squarcina L., Mattisi I., Perini P., Bertoldo A., Gallo P. Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study. Radiology 2011, 261:891-898.
17. Calabrese M., Romualdi C., Poretto V., Favaretto A., Morra A., Rinaldi F., Perini P., Gallo P. The changing clinical course of multiple sclerosis: a matter of gray matter. Ann. Neurol. 2013, 74:76-83.
18. Cate H.S., Wu Q.Z., Kemper D., Merlo D., Wang H.X., Fang K., Egan G.F., Kilpatrick T.J. Influence of methylprednisolone on magnetic resonance and histological measures during cuprizone-induced demyelination. Neurosci. Lett. 2010, 483:47-52.
19. Chandran P., Upadhyay J., Markosyan S., Lisowski A., Buck W., Chin C.L., Fox G., Luo F., Day M. Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice. Neuroscience 2012, 202:446-453.
20. Cheung J.S., Wang E., Lo E.H., Sun P.Z. Stratification of heterogeneous diffusion MRI ischemic lesion with kurtosis imaging: evaluation of mean diffusion and kurtosis MRI mismatch in an animal model of transient focal ischemia. Stroke 2012, 43:2252-2254.
21. Ciccarelli O., Werring D.J., Wheeler-Kingshott C.A., Barker G.J., Parker G.J., Thompson A.J., Miller D.H. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001, 56:926-933.
22. Coutu J.P., Chen J.J., Rosas H.D., Salat D.H. Non-Gaussian water diffusion in aging white matter. Neurobiol. Aging 2014, 35:1412-1421.
23. Crawford D.K., Mangiardi M., Xia X., Lopez-Valdes H.E., Tiwari-Woodruff S.K. Functional recovery of callosal axons following demyelination: a critical window. Neuroscience 2009, 164:1407-1421.
24. Delgado y Palacios R., Campo A., Henningsen K., Verhoye M., Poot D., Dijkstra J., Van Audekerke J., Benveniste H., Sijbers J., Wiborg O., Van der Linden A. Magnetic resonance imaging and spectroscopy reveal differential hippocampal changes in anhedonic and resilient subtypes of the chronic mild stress rat model. Biol. Psychiatry 2011, 70:449-457.
25. Delgado y Palacios R., Verhoye M., Henningsen K., Wiborg O., Van der Linden A. Diffusion kurtosis imaging and high-resolution MRI demonstrate structural aberrations of caudate putamen and amygdala after chronic mild stress. PLoS One 2014, 9.
26. den Dekker A.J., Sijbers J. Data distributions in magnetic resonance images: a review. Phys. Med. 2014, 30:725-741.
27. Falangola M.F., Jensen J.H., Babb J.S., Hu C., Castellanos F.X., Di Martino A., Ferris S.H., Helpern J.A. Age-related non-Gaussian diffusion patterns in the prefrontal brain. J. Magn. Reson. Imaging 2008, 28:1345-1350.
28. Falangola M.F., Guilfoyle D.N., Tabesh A., Hui E.S., Nie X., Jensen J.H., Gerum S.V., Hu C., LaFrancois J., Collins H.R., Helpern J.A. Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone-induced corpus callosum demyelination. NMR Biomed. 2014, 27:948-957.
29. Fieremans E., Jensen J.H., Helpern J.A. White matter characterization with diffusional kurtosis imaging. NeuroImage 2011, 58:177-188.
30. Fieremans E., Benitez A., Jensen J.H., Falangola M.F., Tabesh A., Deardorff R.L., Spampinato M.V., Babb J.S., Novikov D.S., Ferris S.H., Helpern J.A. Novel white matter tract integrity metrics sensitive to Alzheimer disease progression. AJNR Am. J. Neuroradiol. 2013, 34:2105-2112.
31. Filippi M., Preziosa P., Pagani E., Copetti M., Mesaros S., Colombo B., Horsfield M.A., Falini A., Comi G., Lassmann H., Rocca M.A. Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis. Mult. Scler. 2013, 19:418-426.
32. Fox R.J., Cronin T., Lin J., Wang X., Sakaie K., Ontaneda D., Mahmoud S.Y., Lowe M.J., Phillips M.D. Measuring myelin repair and axonal loss with diffusion tensor imaging. AJNR Am. J. Neuroradiol. 2011, 32:85-91.
33. Franklin K., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 1997, Academic Press, San Diego. 3rd edn.
34. Giorgio A., Palace J., Johansen-Berg H., Smith S.M., Ropele S., Fuchs S., Wallner-Blazek M., Enzinger C., Fazekas F. Relationships of brain white matter microstructure with clinical and MR measures in relapsing-remitting multiple sclerosis. J. Magn. Reson. Imaging 2010, 31:309-316.
35. Grossman E.J., Kirov I.I., Gonen O., Novikov D.S., Davitz M.S., Lui Y.W., Grossman R.I., Inglese M., Fieremans E. N-acetyl-aspartate levels correlate with intra-axonal compartment parameters from diffusion MRI. NeuroImage 2015, 118:334-343.
36. Gudi V., Moharregh-Khiabani D., Skripuletz T., Koutsoudaki P.N., Kotsiari A., Skuljec J., Trebst C., Stangel M. Regional differences between grey and white matter in cuprizone induced demyelination. Brain Res. 2009, 1283:127-138.
37. Gudi V., Gingele S., Skripuletz T., Stangel M. Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned. Front. Cell. Neurosci. 2014, 8:73.
38. Guglielmetti C., Praet J., Rangarajan J.R., Vreys R., De Vocht N., Maes F., Verhoye M., Ponsaerts P., Van der Linden A. Multimodal imaging of subventricular zone neural stem/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum. NeuroImage 2014, 86:99-110.
39. Harsan L.A., Steibel J., Zaremba A., Agin A., Sapin R., Poulet P., Guignard B., Parizel N., Grucker D., Boehm N., Miller R.H., Ghandour M.S. Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging. J. Neurosci. 2008, 28:14189-14201.
40. Hemanth Kumar B.S., Mishra S.K., Trivedi R., Singh S., Rana P., Khushu S. Demyelinating evidences in CMS rat model of depression: a DTI study at 7T. Neuroscience 2014, 275:12-21.
41. Hibbits N., Yoshino J., Le T.Q., Armstrong R.C. Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination. ASN Neuro 2012, 4:393-408.
42. Hiremath M.M., Saito Y., Knapp G.W., Ting J.P., Suzuki K., Matsushima G.K. Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J. Neuroimmunol. 1998, 92:38-49.
43. Honce J.M. Gray matter pathology in MS: neuroimaging and clinical correlations. Mult. Scler. Int. 2013, 2013:627870.
44. Horsfield M.A., Jones D.K. Applications of diffusion-weighted and diffusion tensor MRI to white matter diseases - a review. NMR Biomed. 2002, 15:570-577.
45. Hui E.S., Cheung M.M., Qi L., Wu E.X. Towards better MR characterization of neural tissues using directional diffusion kurtosis analysis. NeuroImage 2008, 42:122-134.
46. Hui E.S., Fieremans E., Jensen J.H., Tabesh A., Feng W., Bonilha L., Spampinato M.V., Adams R., Helpern J.A. Stroke assessment with diffusional kurtosis imaging. Stroke 2012, 43:2968-2973.
47. Janve V.A., Zu Z., Yao S.Y., Li K., Zhang F.L., Wilson K.J., Ou X., Does M.D., Subramaniam S., Gochberg D.F. The radial diffusivity and magnetization transfer pool size ratio are sensitive markers for demyelination in a rat model of type III multiple sclerosis (MS) lesions. NeuroImage 2013, 74:298-305.
48. Jelescu I.O., Veraart J., Adisetiyo V., Milla S.S., Novikov D.S., Fieremans E. One diffusion acquisition and different white matter models: how does microstructure change in human early development based on WMTI and NODDI?. NeuroImage 2015, 107:242-256.
49. Jensen J.H., Helpern J.A. MRI quantification of non-Gaussian water diffusion by kurtosis analysis. NMR Biomed. 2010, 23:698-710.
50. Jensen J.H., Helpern J.A., Ramani A., Lu H., Kaczynski K. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn. Reson. Med. 2005, 53:1432-1440.
51. Kim J.Y., Shen S., Dietz K., He Y., Howell O., Reynolds R., Casaccia P. HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage. Nat. Neurosci. 2010, 13:180-189.
52. Kimura M.C., Doring T.M., Rueda F.C., Tukamoto G., Gasparetto E.L. In vivo assessment of white matter damage in neuromyelitis optica: a diffusion tensor and diffusion kurtosis MR imaging study. J. Neurol. Sci. 2014, 345:172-175.
53. Kipp M., Clarner T., Dang J., Copray S., Beyer C. The cuprizone animal model: new insights into an old story. Acta Neuropathol. 2009, 118:723-736.
54. Klawiter E.C., Schmidt R.E., Trinkaus K., Liang H.F., Budde M.D., Naismith R.T., Song S.K., Cross A.H., Benzinger T.L. Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords. NeuroImage 2011, 55:1454-1460.
55. Kutzelnigg A., Lassmann H. Cortical lesions and brain atrophy in MS. J. Neurol. Sci. 2005, 233:55-59.
56. Kutzelnigg A., Lucchinetti C.F., Stadelmann C., Bruck W., Rauschka H., Bergmann M., Schmidbauer M., Parisi J.E., Lassmann H. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005, 128:2705-2712.
57. Le Bihan D., Mangin J.F., Poupon C., Clark C.A., Pappata S., Molko N., Chabriat H. Diffusion tensor imaging: concepts and applications. J. Magn. Reson. Imaging 2001, 13:534-546.
58. Lindner M., Trebst C., Heine S., Skripuletz T., Koutsoudaki P.N., Stangel M. The chemokine receptor CXCR2 is differentially regulated on glial cells in vivo but is not required for successful remyelination after cuprizone-induced demyelination. Glia 2008, 56:1104-1113.
59. Lucchinetti C.F., Popescu B.F., Bunyan R.F., Moll N.M., Roemer S.F., Lassmann H., Bruck W., Parisi J.E., Scheithauer B.W., Giannini C., Weigand S.D., Mandrekar J., Ransohoff R.M. Inflammatory cortical demyelination in early multiple sclerosis. N. Engl. J. Med. 2011, 365:2188-2197.
60. Marriott M.P., Emery B., Cate H.S., Binder M.D., Kemper D., Wu Q., Kolbe S., Gordon I.R., Wang H., Egan G., Murray S., Butzkueven H., Kilpatrick T.J. Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair. Glia 2008, 56:686-698.
61. Mason J.L., Jones J.J., Taniike M., Morell P., Suzuki K., Matsushima G.K. Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J. Neurosci. Res. 2000, 61:251-262.
62. Matsushima G.K., Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001, 11:107-116.
63. Merkler D., Boretius S., Stadelmann C., Ernsting T., Michaelis T., Frahm J., Bruck W. Multicontrast MRI of remyelination in the central nervous system. NMR Biomed. 2005, 18:395-403.
64. Orije J., Kara F., Guglielmetti C., Praet J., Van der Linden A., Ponsaerts P., Verhoye M. Longitudinal monitoring of metabolic alterations in cuprizone mouse model of multiple sclerosis using 1H-magnetic resonance spectroscopy. NeuroImage 2015, 114:128-135.
65. Ou X., Sun S.W., Liang H.F., Song S.K., Gochberg D.F. The MT pool size ratio and the DTI radial diffusivity may reflect the myelination in shiverer and control mice. NMR Biomed. 2009, 22:480-487.
66. Patel S.A., Hum B.A., Gonzalez C.F., Schwartzman R.J., Faro S.H., Mohamed F.B. Application of voxelwise analysis in the detection of regions of reduced fractional anisotropy in multiple sclerosis patients. J. Magn. Reson. Imaging 2007, 26:552-556.
67. Paydar A., Fieremans E., Nwankwo J.I., Lazar M., Sheth H.D., Adisetiyo V., Helpern J.A., Jensen J.H., Milla S.S. Diffusional kurtosis imaging of the developing brain. AJNR Am. J. Neuroradiol. 2014, 35:808-814.
68. Poot D.H., den Dekker A.J., Achten E., Verhoye M., Sijbers J. Optimal experimental design for diffusion kurtosis imaging. IEEE Trans Med Imaging 2010, 29:819-829.
69. Praet J., Guglielmetti C., Berneman Z., Van der Linden A., Ponsaerts P. Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis. Neurosci. Biobehav. Rev. 2014, 47:485-505.
70. Praet J., Orije J., Kara F., Guglielmetti C., Santermans E., Daans J., Hens N., Verhoye M., Berneman Z., Ponsaerts P., Van der Linden A. Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra. NMR Biomed. 2015, 28:505-513.
71. R Core Team R: A language and environment for statistical computing 2014, R Foundation for Statistical Computing, Vienna, Austria., http://www.R-project.org/.
72. Raab P., Hattingen E., Franz K., Zanella F.E., Lanfermann H. Cerebral gliomas: diffusional kurtosis imaging analysis of microstructural differences. Radiology 2010, 254:876-881.
73. Raz E., Bester M., Sigmund E.E., Tabesh A., Babb J.S., Jaggi H., Helpern J., Mitnick R.J., Inglese M. A better characterization of spinal cord damage in multiple sclerosis: a diffusional kurtosis imaging study. AJNR Am. J. Neuroradiol. 2013, 34:1846-1852.
74. Remington L.T., Babcock A.A., Zehntner S.P., Owens T. Microglial recruitment, activation, and proliferation in response to primary demyelination. Am. J. Pathol. 2007, 170:1713-1724.
75. Roosendaal S.D., Geurts J.J., Vrenken H., Hulst H.E., Cover K.S., Castelijns J.A., Pouwels P.J., Barkhof F. Regional DTI differences in multiple sclerosis patients. NeuroImage 2009, 44:1397-1403.
76. Sbardella E., Tona F., Petsas N., Pantano P. DTI measurements in multiple sclerosis: evaluation of brain damage and clinical implications. Mult. Scler. Int. 2013, 2013:671730.
77. Semple B.D., Blomgren K., Gimlin K., Ferriero D.M., Noble-Haeusslein L.J. Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species. Prog. Neurobiol. 2013, 106-107:1-16.
78. Skripuletz T., Lindner M., Kotsiari A., Garde N., Fokuhl J., Linsmeier F., Trebst C., Stangel M. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am. J. Pathol. 2008, 172:1053-1061.
79. Skripuletz T., Gudi V., Hackstette D., Stangel M. De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected. Histol. Histopathol. 2011, 26:1585-1597.
80. Song S.K., Sun S.W., Ramsbottom M.J., Chang C., Russell J., Cross A.H. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. NeuroImage 2002, 17:1429-1436.
81. Song S.K., Yoshino J., Le T.Q., Lin S.J., Sun S.W., Cross A.H., Armstrong R.C. Demyelination increases radial diffusivity in corpus callosum of mouse brain. NeuroImage 2005, 26:132-140.
82. Steelman A.J., Thompson J.P., Li J. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication. Neurosci. Res. 2012, 72:32-42.
83. Sun S.W., Liang H.F., Trinkaus K., Cross A.H., Armstrong R.C., Song S.K. Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magn. Reson. Med. 2006, 55:302-308.
84. Thiessen J.D., Zhang Y., Zhang H., Wang L., Buist R., Del Bigio M.R., Kong J., Li X.M., Martin M. Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination. NMR Biomed. 2013, 26:1562-1581.
85. Tobin J.E., Xie M., Le T.Q., Song S.K., Armstrong R.C. Reduced axonopathy and enhanced remyelination after chronic demyelination in fibroblast growth factor 2 (Fgf2)-null mice: differential detection with diffusion tensor imaging. J. Neuropathol. Exp. Neurol. 2011, 70:157-165.
86. Torkildsen O., Brunborg L.A., Thorsen F., Mork S.J., Stangel M., Myhr K.M., Bo L. Effects of dietary intervention on MRI activity, de- and remyelination in the cuprizone model for demyelination. Exp. Neurol. 2009, 215:160-166.
87. Tovar-Moll F., Evangelou I.E., Chiu A.W., Richert N.D., Ostuni J.L., Ohayon J.M., Auh S., Ehrmantraut M., Talagala S.L., McFarland H.F., Bagnato F. Thalamic involvement and its impact on clinical disability in patients with multiple sclerosis: a diffusion tensor imaging study at 3T. AJNR Am. J. Neuroradiol. 2009, 30:1380-1386.
88. Tsiperson V., Li X., Schwartz G.J., Raine C.S., Shafit-Zagardo B. GAS6 enhances repair following cuprizone-induced demyelination. PLoS One 2010, 5.
89. Umesh Rudrapatna S., Wieloch T., Beirup K., Ruscher K., Mol W., Yanev P., Leemans A., van der Toorn A., Dijkhuizen R.M. Can diffusion kurtosis imaging improve the sensitivity and specificity of detecting microstructural alterations in brain tissue chronically after experimental stroke? Comparisons with diffusion tensor imaging and histology. NeuroImage 2014, 97:363-373.
90. Van Cauter S., Veraart J., Sijbers J., Peeters R.R., Himmelreich U., De Keyzer F., Van Gool S.W., Van Calenbergh F., De Vleeschouwer S., Van Hecke W., Sunaert S. Gliomas: diffusion kurtosis MR imaging in grading. Radiology 2012, 263:492-501.
91. Vanhoutte G., Pereson S., Delgado Y.P.R., Guns P.J., Asselbergh B., Veraart J., Sijbers J., Verhoye M., Van Broeckhoven C., Van der Linden A. Diffusion kurtosis imaging to detect amyloidosis in an APP/PS1 mouse model for Alzheimer's disease. Magn. Reson. Med. 2013, 69:1115-1121.
92. Veraart J., Poot D.H., Van Hecke W., Blockx I., Van der Linden A., Verhoye M., Sijbers J. More accurate estimation of diffusion tensor parameters using diffusion Kurtosis imaging. Magn. Reson. Med. 2011, 65:138-145.
93. Veraart J., Rajan J., Peeters R.R., Leemans A., Sunaert S., Sijbers J. Comprehensive framework for accurate diffusion MRI parameter estimation. Magn. Reson. Med. 2013, 70:972-984.
94. Verma R., Mori S., Shen D., Yarowsky P., Zhang J., Davatzikos C. Spatiotemporal maturation patterns of murine brain quantified by diffusion tensor MRI and deformation-based morphometry. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:6978-6983.
95. Wang S., Wu E.X., Qiu D., Leung L.H., Lau H.F., Khong P.L. Longitudinal diffusion tensor magnetic resonance imaging study of radiation-induced white matter damage in a rat model. Cancer Res. 2009, 69:1190-1198.
96. Wergeland S., Torkildsen O., Myhr K.M., Mork S.J., Bo L. The cuprizone model: regional heterogeneity of pathology. APMIS 2012, 120:648-657.
97. Wu E.X., Cheung M.M. MR diffusion kurtosis imaging for neural tissue characterization. NMR Biomed. 2010, 23:836-848.
98. Wu Q.Z., Yang Q., Cate H.S., Kemper D., Binder M., Wang H.X., Fang K., Quick M.J., Marriott M., Kilpatrick T.J., Egan G.F. MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model. J. Magn. Reson. Imaging 2008, 27:446-453.
99. Xie M., Tobin J.E., Budde M.D., Chen C.I., Trinkaus K., Cross A.H., McDaniel D.P., Song S.K., Armstrong R.C. Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features. J. Neuropathol. Exp. Neurol. 2010, 69:704-716.
100. Yang H.J., Wang H., Zhang Y., Xiao L., Clough R.W., Browning R., Li X.M., Xu H. Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: implications for the pathophysiology of schizophrenia. Brain Res. 2009, 1270:121-130.
101. Yang A.W., Jensen J.H., Hu C.C., Tabesh A., Falangola M.F., Helpern J.A. Effect of cerebral spinal fluid suppression for diffusional kurtosis imaging. J. Magn. Reson. Imaging 2013, 37:365-371.
102. Yoshida M., Hori M., Yokoyama K., Fukunaga I., Suzuki M., Kamagata K., Shimoji K., Nakanishi A., Hattori N., Masutani Y., Aoki S. Diffusional kurtosis imaging of normal-appearing white matter in multiple sclerosis: preliminary clinical experience. Jpn. J. Radiol. 2013, 31:50-55.
103. Zhang J., Jones M.V., McMahon M.T., Mori S., Calabresi P.A. In vivo and ex vivo diffusion tensor imaging of cuprizone-induced demyelination in the mouse corpus callosum. Magn. Reson. Med. 2012, 67:750-759.
104. Zhu J., Zhuo C., Qin W., Wang D., Ma X., Zhou Y., Yu C. Performances of diffusion kurtosis imaging and diffusion tensor imaging in detecting white matter abnormality in schizophrenia. Neuroimage Clin. 2015, 7:170-176.
105. Zhuo J., Xu S., Proctor J.L., Mullins R.J., Simon J.Z., Fiskum G., Gullapalli R.P. Diffusion kurtosis as an in vivo imaging marker for reactive astrogliosis in traumatic brain injury. NeuroImage 2012, 59:467-477.